<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>AstraZeneca - nyheter</title>
    <link>http://www.mynewsdesk.com/no/pressroom/astrazeneca/news/list</link>
    <description>Mynewsdesk nyhetsstrøm direkte fra kilden</description>
    <image>
      <title>AstraZeneca - nyheter</title>
      <link>http://www.mynewsdesk.com/no/pressroom/astrazeneca/news/list</link>
      <url>http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png</url>
      <width>128</width>
      <height>23</height>
    </image>
    <language>sv</language>
    <ttl>15</ttl>
<item>
  <title>Regjeringen foreslår å inkludere ny hjertemedisin på blå resept</title>
  <pubDate>Thu, 10 Nov 2011 10:38:52 +0100</pubDate>
  <description>http://www.regjeringen.no/nb/dep/hod/pressesenter/pressemeldinger/2011/regjeringen-foreslar-a-inkludere-ny-hjer.html?id=662223</description>
  <guid>http://www.mynewsdesk.com/no/pressroom/astrazeneca/news/view/regjeringen-foreslaar-aa-inkludere-ny-hjertemedisin-paa-blaa-resept-31127?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=news</guid>
  <link>http://www.mynewsdesk.com/no/pressroom/astrazeneca/news/view/regjeringen-foreslaar-aa-inkludere-ny-hjertemedisin-paa-blaa-resept-31127?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=news</link>
  <dc:creator>AstraZeneca AB</dc:creator>
</item>
<item>
  <title>Informasjonsseminar om lungekreft</title>
  <pubDate>Fri, 04 Nov 2011 13:55:52 +0100</pubDate>
  <description>Lungekreftforeningen inviterer pasienter, pårørende, helsepersonell eller generelt interesserte til gratis informasjonsseminar. Les mer om datoer og steder her: </description>
  <guid>http://www.mynewsdesk.com/no/pressroom/astrazeneca/news/view/informasjonsseminar-om-lungekreft-30821?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=news</guid>
  <link>http://www.mynewsdesk.com/no/pressroom/astrazeneca/news/view/informasjonsseminar-om-lungekreft-30821?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=news</link>
  <dc:creator>AstraZeneca AB</dc:creator>
</item>
  </channel>
</rss>
